enVVeno Medical (NVNO) Shares Outstanding (2017 - 2026)
enVVeno Medical's (NVNO) quarterly Shares Outstanding (Entity) came in at $270615.0 in Q3 2023, little changed year-on-year from $270615.0 in Q3 2022, and little changed quarter-over-quarter from $270615.0 in Q2 2023.
enVVeno Medical (NVNO) Shares Outstanding (2017 - 2026) Analysis & Trends
enVVeno Medical's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $270615.0 for Q3 2023.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $270615.0 in Q3 2023; TTM through Sep 2023 was $270615.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $270615.0, changed 0.02% from the prior year.
- Shares Outstanding (Entity) was little changed at $270615.0 in Q3 2023 per NVNO's latest filing, from $270615.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $270615.0 in Q3 2022 and bottomed at $321.0 in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $164026.0 (2021), against an average of $146243.2.
- Across the five-year window, Shares Outstanding (Entity) tumbled 99.87% in 2022 and surged 84203.74% in 2023, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $20493.0 in 2019, then soared by 80.05% to $36897.0 in 2020, then jumped by 633.27% to $270554.0 in 2021, then climbed by 0.02% to $270615.0 in 2022, then changed by 0.0% to $270615.0 in 2023.
- Per Business Quant, the three latest NVNO Shares Outstanding (Entity) figures stand at $270615.0 (Q3 2023), $270615.0 (Q2 2023), and $270615.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | 654,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 654,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | 575,828.00 |
| Jun 30, 2025 | 581,457.00 |
| Mar 31, 2025 | 581,457.00 |
| Dec 31, 2024 | 489,747.00 |
| Sep 30, 2024 | 459,034.00 |
| Jun 30, 2024 | 459,034.00 |
| Mar 31, 2024 | 458,748.00 |
| Dec 31, 2023 | 351,440.00 |
| Sep 30, 2023 | 320,870.00 |
| Jun 30, 2023 | 320,870.00 |
| Mar 31, 2023 | 320,870.00 |
| Dec 31, 2022 | 320,841.00 |
| Sep 30, 2022 | 320,813.00 |
| Jun 30, 2022 | 321.00 |
| Mar 31, 2022 | 320,813.00 |
| Dec 31, 2021 | 247,983.00 |
| Sep 30, 2021 | 262,259.00 |
| Jun 30, 2021 | 243,190.00 |